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Summary
Ossification of the posterior longitudinal ligament of the
spine (OPLL) is recognized as a common disorder among
Japanese and throughout Asia. Estimates of its preva-
lence are in the range of 1.9%–4.3%. Although its eti-
ology is thought to involve a multiplicity of factors, ep-
idemiological and family studies strongly implicate
genetic susceptibility in the pathogenesis of OPLL. In
this study we report an identification of a predisposing
locus for OPLL, on chromosome 6p, close to the HLA
complex. The evidence for this localization is provided
by a genetic-linkage study of 91 affected sib pairs from
53 Japanese families. In this sib-pair study, D6S276, a
marker lying close to the HLA complex, gives evidence
for strongly significant linkage (P  .000006) to the
OPLL locus. A candidate gene in the region, that for
collagen 11A2, was analyzed for the presence of molec-
ular variants in affected probands. Of 19 distinct vari-
ants identified, 4 showed strong statistical associations
with OPLL (highest P  .0004). These observations of
linkage and association, taken together, show that a ge-
netic locus for OPLL lies close to the HLA region, on
chromosome 6p.
Introduction
Ossification of the posterior longitudinal ligament
(OPLL) in the spine is characterized by heterotopic bone
formation in spinal ligaments, through endochondral
mechanisms. It constitutes the leading cause of spinal-
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canal stenosis and myelopathy among Japanese, with a
reported prevalence of 1.9%–4.3% (Matsunaga and
Sakou 1997). This condition has also been recognized
in outpatient clinics in the United States and Europe,
where the prevalence is 0.01%–1.7% (Matsunaga and
Sakou 1997). A related ossification disorder, diffuse id-
iopathic skeletal hyperostosis (DISH), or Forestier dis-
ease, has been described and characterized in Caucasian
populations, by Resnick (1976). In DISH, bone prolif-
eration occurs in spinal and extraspinal locations; how-
ever, in 50% of these cases, ossification of the posterior
lateral ligaments was also found (Resnick et al. 1978).
Recently, a DISH prevalence estimate of 25% in males
and 15% in females, at age 150 years, has been found
in a Caucasian population of consecutive patients, by
means of posterior/anterior and lateral chest radiographs
(Weinfeld et al. 1997). The extent of overlap of OPLL
with DISH is unknown, but several investigators support
the concept that OPLL represents a clinical subset of
DISH (Trojan et al. 1992).
The average age at onset of OPLL is ∼50 years in both
men and women, although the male:female ratio is 2:1.
Diagnosis of OPLL is confirmed by the finding of os-
sification of the spinal ligaments in transverse x-ray
views of the cervical/thoracic/lumber vertebral column.
Typical symptoms of this disease include sensory and
motor dysfunction of the upper and lower extremities,
bladder dysfunction, and abnormal reflexes. These mye-
lopathies are likely to progress insidiously and chroni-
cally and are not relieved by conservative treatments. If
myelopathy has progressed severely, then surgical inter-
vention such as decompressive laminectomy or decom-
pressive anterior fusion is recommended.
In spite of numerous investigations undertaken to clar-
ify the various mechanisms involved in the ossification
of the ligament, the primary determinants of OPLL have
not been elucidated. Several lines of evidence—including
pedigree studies, twin studies (Uehara et al. 1994), and
an increased (28.9%) risk in siblings of affected indi-
viduals (Terayama 1989)—suggest the existence of ge-
netic factors or loci responsible for the etiology of OPLL.
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Figure 1 Radiological and histologic findings for OPLL. a, X-
ray tomogram of the cervical spine from a typical OPLL subject. The
heterotopic ossification of the posterior longitudinal ligament is ob-
served between C3 and C6 (arrows). The patient showed myelopathy
in upper and lower limbs, which was due to the compression of the
spinal cord. b, Schematic drawing of x-ray radiogram findings. c,MRI,
which clearly shows compression of the spinal cord (arrowhead). d,
Typical histologic examination from an autopsy case with OPLL. The
sagittal section of C3–C6 was stained with hematoxylin-eosin (mag-
nification #28). o  ossified tissue; cz  calcified zone; and c 
cartilage tissue.
Relative risk to the sibling is estimated as 10. Segregation
anaylses in families have supported both autosomal
dominant and autosomal recessive patterns of inheri-
tance (Terayama 1989; Uehara et al. 1994). In 9 of 39
sibships investigated by Terayama (1989), one parent
was found to be affected. However, the mode of inher-
itance is obscured by a lack of large Japanese families,
the late onset of the disease, a sex difference, and en-
vironmental effects. An important first step in under-
standing the role of genetic factors in OPLL is the report,
by Sakou et al. (1991), of an allelic association (P ! .01)
of the HLA markers DR2 and Bw62 with OPLL. In
addition, the siblings in that report, who had HLA hap-
lotypes identical to those in the probands, showed a high
incidence of OPLL.
On the basis of this reported HLA association, we
used genetic-linkage methods to test the hypothesis that
a gene predisposed to the OPLL phenotype resides on
chromosome 6p. Seven highly informative dinucleotide
markers at the HLA complex were selected for the ge-
netic study. Since the mode of inheritance for OPLL is
uncertain, we initially chose to use the nonparametric
affected-sib-pair method, an analysis method indepen-
dent of transmission model. Affected sib pairs were as-
certained by five orthopedic centers in Japan. A total of
91 sib pairs from 53 sibships were analyzed.
A candidate gene for OPLL lies in the region under
study. COL11A2, the gene for the collagen a2 (XI)
chain, lies between the markers D6S291 and D6S273,
in the same interval that contains the HLA-DR2 locus.
We performed an extensive SSCP analysis onCOL11A2,
to screen the molecular variants contributing to the dis-
ease. Nineteen distinct variants thus far have been iden-
tified in COL11A2. Statistically positive associations be-
tween OPLL and several molecular variants were
detected. For the purpose of predicting the disease-sus-
ceptibility allele in the gene, haplotype analysis based
on maximum likelihood was performed. Estimated fre-
quencies of haplotypes with four variants that exhibit
positive associations were compared, between OPLL pa-
tients and control subjects. The haplotype should exhibit
a variable degree of association with the causal muta-
tion(s) and, thus, with OPLL. In fact, we detected strong
associations with two specific haplotypes in OPLL
subjects.
When taken together, these results—including genetic
linkage, allelic association, and haplotype analy-
sis—demonstrate that a genetic locus for OPLL lies close
to the HLA region. Possible involvement of COL11A2
in OPLL needs to be investigated further.
Subjects and Methods
Disease Criteria and Selection of Subjects
The diagnosis of OPLL was based both on the findings
of symptoms by physical examination and on radiolog-
ical findings (fig. 1). An individual was classified as af-
fected if ossification was observed in any vertebrae of
the cervical or thoracic portion of the spine. In general,
the region of ossification occupied from 10% to 150%
of the anterior part of the spinal canal. The ossification
type was classified according to the criteria defined by
the Investigation Committee on the Ossification of the
Spinal Ligaments, Japanese Ministry of Public Health
and Welfare. The appearance of OPLL observed in ra-
diographs is classified into four types: (1) segmental, (2)
continuous, (3) mixed, and (4) localized, circumscribed,
or bridged. All four types of OPLL were identified in
this study. The predominant type was segmental. All
subjects were diagnosed by T.S, H.K., E.T, S.H., and
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T.N. The study included 124 siblings, 46 females and
78 males, from 53 Japanese families. Subjects were re-
cruited from five university hospital clinics, in Kago-
shima, Wakayama, Asahikawa, Okinawa, and Hirosaki.
All studies were conducted in accordance with human-
subject standards set by the respective universities, and
informed consent was obtained from the subjects prior
to enrollment. Twenty-nine pairs, 12 trios, and 1 quartet
were collected in Kagoshima; 4 pairs, 2 trios, and 1
quartet were collected in Hirosaki; 2 pairs were collected
in Asahikawa; 1 pair was collected in Wakayama; and
1 pair was collected in Okinawa. The study samples
comprise 91 pairs (46 females and 78 males). The af-
fected sibships are composed of 37 pairs, 14 trios, and
2 quartets of OPLL siblings.
To determine accurately the allele frequencies in the
general Japanese population, DNA samples were ob-
tained from 212 healthy control (non-OPLL) individuals
(136 females and 76 males) with normal spinal x-rays.
The average age in this control group was 69.0 years
(range 40–95 years). One hundred eighty-three controls
(125 females and 58males) were collected inKagoshima,
and 29 controls (11 females and 18males) were collected
in Hirosaki. To supplement the number of OPLL pa-
tients (affected sib pairs) in the association study with
COL11A2 gene polymorphisms, additional DNA sam-
ples were obtained from 137 patients (33 females and
104 males). The average age in this group was 60.6 years
(range 41–81 years). One hundred twenty-one of these
cases (29 females and 92 males) were collected in Ka-
goshima, and 16 (4 females and 12 males) were collected
in Hirosaki.
Genotyping of Microsatellite Markers
DNA was extracted either from whole blood or from
lymphoblastoid cell lines, by standard phenol-chloro-
form protocols. PCR reactions were performed in a 25-
ml final volume containing 200 ng of genomic DNA, 200
mM each dNTP, 0.25 mM spermidine (Sigma Chemi-
cals), 0.25 pmol of end-labeled primer, 10 pmol each of
unlabeled forward and reverse primers, 1.25 ml of di-
methyl sulfoxide, 0.1 U of Taq DNA polymerase, and
1 # PCR buffer (Boehringer Mannheim). Amplified
products were loaded onto 7% polyacrylamide/8Murea
sequencing gels and were run for 4–5 h at 80W. Samples
from the same sibship were loaded into the gels in ad-
jacent lanes. Gels were placed immediately on Hyper-
film MP (Amersham) and were exposed at 70C for
16 h. On the basis of the films, genotypes were scored
by two independent observers. A size standard derived
from an M13 dideoxy sequencing ladder was included
every 20 lanes, for accurate determination of allelic sizes.
Alleles were scored according to their sizes (in base
pairs). The number of observed alleles per marker system
was 6–12. All markers had heterozygosities 170%, with
the exception of D6S285, which had an observed het-
erozygosity of 41.3%.
SSCP Analysis of COL11A2
A total of 20 OPLL probands and 10 non-OPLL con-
trol subjects were initially screened for molecular vari-
ants. SSCP screening was performed on PCR-amplified
segments spanning all 66 exons of the collagen gene, 2.6
kb of intron 1, and 0.6 kb of intron 6, as well as 1.3
kb of genomic sequence upstream of the transcriptional
start site. A total of 165 primer sets were made to com-
pletely cover these genomic regions. These primer sets
were designed from the human gene sequence, obtained
from the EMBL-NEW5 database, accession number
U32169 (primer sequences used in this study are avail-
able, on request, from the authors). PCR-SSCP analysis
was performed as described elsewhere (Orita et al.
1989), with modifications. Samples were loaded onto a
mutation detection–enhancement gel, according to the
manufacturer’s protocol (FMC). Gels were run in the
presence or absence of glycerol, at room temperature.
In order to screen GC-rich promoter segments, a mixture
of dGTP (100 mM) and 7-deaza-2′-deoxyguanosine (100
mM) was added to the PCR reaction, according to the
protocol of McConlogue et al. (1988). Variants detected
by SSCP analysis were subjected to direct sequencing by
a Taq DyeDeoxy Terminator protocol on an ABI 373A
sequencing instrument (Applied Biosystems), as de-
scribed elsewhere (Hata et al. 1990). When a variant
was confirmed by DNA sequencing, the frequency of
SSCP variants was compared between OPLL patients
and controls. A total of 137 cases and 183 controls were
typed for each SSCP polymorphism. The differences in
the genotype frequency, between cases and controls,
were analyzed by the x2 test statistic.
Linkage Analysis and Statistics
Identity-by-descent sib-pair analysis was performedby
the SIBPAIR program from the computer package
ANALYZE, version 2.1, by J. D. Terwilliger, obtainable
at the Columbia Website. Allelic frequencies evaluated
in the 138 Japanese non-OPLL controls, as described
above (see the Genotyping ofMicrosatelliteMarkers sec-
tion), were used in all linkage calculations. The haplo-
type frequencies were estimated by the maximum-like-
lihood method, by means of a simplified version of the
computer program GENEF (Jeunemaitre et al. 1997).
Results
Clinical Features of OPLL
OPLL is usually diagnosed by radiographic methods,
and the ossification is recognized along the posterior
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Table 1
Sib-Pair Linkage Analysis (Identical
by Descent) of the HLA Region
Locus P
D6S285 .046
D6S299 .15
D6S276 .0000059
D6S265 .086
D6S273 .042
D6S291 .077
D6S426 .080
margin of the vertebral bodies (figs. 1a and b). Most of
the patients have some clinical symptoms, such as cer-
vical pain or discomfort in conjunction with numbness
of the upper limbs. With growth of the ossified mass,
the spinal canal is compressed, resulting in severe mye-
lopathy. Magnetic-resonance imaging (MRI) clearly
demonstrates the compression of the spinal cord (fig.
1c). The typical results of histologic examination of an
autopsy case with OPLL is shown in figure 1d. The sag-
ittal section of C3–C6 shows the huge tumorlike ossified
mass of the posterior longitudinal ligaments, growing
longitudinally along the posterior aspect of the vertebral
bodies. In front of the ossification foci, endochondral
ossification of the calcified zone is observed. In this zone,
different thicknesses bordering on the ossified tissue are
seen. Numerous chondrocytes also accumulate in the
remote area.
Linkage Analysis
We tested for linkage of OPLL to multiple markers in
the chromosome 6p region, using the SIBPAIR program
in ANALYZE. A total of 91 affected sib pairs from five
different orthopedic centers in Japan were analyzed. Ra-
diological findings were obtained on all patients. Because
this analysis is sensitive to marker-allele frequency, we
determined reference frequencies in a Japanese sample
of healthy controls (n  212) who had undergone x-ray
examination and who were free of any ossification in
their spinal ligaments. In all, seven dinucleotide-repeat
markers flanking the HLA locus were tested for linkage
to the disease phenotype. The order assumed for these
markers is based on genetic and physical maps of this
region (Martin et al. 1995; Feder et al. 1996; also see
Whitehead Institute for Biomedical Research/MIT Cen-
ter for Genome Research). From proximal to distal, the
order is D6S426–(11 cM)–D6S291–(4 cM [interval in-
cludes HLA-DR locus])–D6S273–(1 cM)–D6S265–
(!1 cM)–D6S276–(4 cM)–D6S299–(8 cM)–D6S285.
Among these markers, significant genetic linkage was
detected in the (identical by descent) sib-pair analysis (P
 6# 106), with the marker D6S276, which is located
distally to the HLA locus. The equivalent LOD score for
this marker is 4.18, and the excess sharing of alleles is
14.8%.
Table 1 gives the results of the sib-pair analysis, for
all seven markers. Haplotype analysis of all families
shows that, at three marker loci—including D6S276, the
marker with the most significant indication of link-
age—three individuals (a female in kindred 18, a female
in kindred 46, and a male in kindred 56) do not share
the disease haplotype with their siblings. These three
families are clear evidence that either more than one
genetic locus exists for this condition or that nongenetic
causes are also involved. If these families are excluded,
then alleles are shared between all affected sib pairs (n
 86) in the 50 remaining families, for the adjacent
markers D6S276 and D6S265. In an attempt to formally
demonstrate locus heterogeneity, we analyzed the entire
set of 53 families, for admixture among families, using
the HOMOG test (Terwilliger and Ott 1994). For each
of the seven marker loci tested, no significant evidence
for a second locus was obtained; the most suggestive
evidence for heterogeneity was obtained with marker
D6S265 (x2  1, df  2.045, P  .076). Interestingly,
four individuals within the families were excluded from
the study because they did not meet the strict disease
criteria of OPLL. Three individuals from separate fam-
ilies were diagnosed with ossification of the anterior lig-
aments of the spine, and one individual was diagnosed
with ossification of other spinal ligaments (balsomy).
When the haplotypes of all four individuals were ex-
amined, it was observed that all possessed the disease
haplotype seen in their affected siblings.
Mutation Search in the COL11A2 Gene
As a candidate gene, COL11A2 was extensively
screened for molecular variants in OPLL subjects. We
performed a systematic SSCP analysis to screen for ge-
netic mutations in all 66 exons and 1,300 bp of the 5′
noncoding region of the gene (Vuristo et al. 1995). In
addition, regions known to be involved in splice vari-
ants—intron 6, intron 1, and a region associated with
tissue-specific expression in the mouse (Lui et al. 1996;
Tsumaki et al. 1996)—were also completely screened for
mutations. Nineteen different molecular variants have
been identified throughout the gene (table 2). Five of the
variants (D593G, E824K, L879P, P1316T, and
R1600Q) lead to amino acid changes in the coding
regions. Among these variants, E824K and L879P were
fairly frequent both in OPLL subjects and in controls,
with no statistical differences between the groups (table
2). No mutation was detected in the key glycine residues
of the triple-helix domain (exons 14–63) that could be
the cause of a more severe phenotype, such as that ob-
served in osteogenesis imperfecta (Francomano 1995).
All 19 variants were subsequently detected in our control
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Table 2
Polymorphisms in COL11A2, and Their Association with OPLL
LOCATION
(POSITIONa)
NUCLEOTIDE
SUBSTITUTION
AMINO ACID
CHANGE
ALLELE FREQUENCYb
x2 (df  1) POPLL Non-OPLL
Promoter (182) ArC .24 (n  128) .33 (n  173) 5.10 .0240
Exon 1 (24) GrA UTR .06 (n  93) .06 (n  70) .02 .8825
Intron 1 (1910) GrA .06 (n  123) .09 (n  148) 1.39 .2390
Intron 6 (353) CrG ND ND
Intron 6 (608) CrT ND ND
Intron 6 (4) TrA .14 (n  129) .26 (n  152) 12.70 .0004
Intron 9 (10) ArG ND ND
Exon 20 (21) ArG DrG (593) ND ND
Intron 20 (32) CrG ND ND
Intron 22 (70) GrT ND ND
Exon 27 (21) TrA GrG (712) .16 (n  124) .20 (n  68) 1.05 .3050
Exon 32 (36) TrC SrS (822) ND ND
Exon 32 (42) GrA ErK (824) .17 (n  106) .15 (n  89) .41 .5230
Intron 35 (3) GrA ND ND
Exon 36 (42) CrT LrP (879) .15 (n  105) .14 (n  87) .07 .7870
Exon 43 (24) ArG PrP (1058) .29 (n  105) .39 (n  149) 5.37 .0210
Exon 46 (18) CrT PrP (1128) .15 (n  130) .22 (n  172) 4.53 .0333
Exon 54 (40) CrA PrT (1316) ND ND
Exon 64 (49) GrA RrQ (1600) .03 (n  116) .02 (n  66) .40 .5288
a Indicates the nucleotide at the start of the exon or intron, with the exception of intron 6, in which the number refers to its position from
the start of exon 7.
b ND  not determined (because of low frequency).
population; no obvious disease-causing mutation was
identified. Allelic frequencies were compared between
cases and controls; the results of this association study
with COL11A2 polymorphisms are presented in table
2. Statistically significant associations were detectedwith
four molecular variants—an ArC substitution at posi-
tion 182 in the promoter region (x2  1, df  5.10,
P  .024), a TrA substitution at position 636 in intron
6 (4 bases upstream from the start of exon 7) (x2  1,
df  12.70, P  .0004), an ArG substitution in exon
43 (x2 1, df 5.37, P .021), and a CrT substitution
in exon 46 (x2  1, df  4.53, P  .033).
Testing Haplotypes in OPLL Patients and Controls
Haplotype estimation was performed by maximum
likelihood. When four polymorphisms (position 182,
intron 6, exon 43, and exon 46) were examined jointly,
maximum-likelihood analysis revealed marked linkage
disequilibrium, with four predominant haplotypes. Es-
timated haplotype frequencies for the four predominant
haplotypes (H1–H4) were compared between OPLL pa-
tients and controls (table 3). Surprisingly, for two of the
four common haplotypes, significant differencesbetween
cases and controls were noted; one of these haplotypes
(H1), consisting of all common alleles at each site, oc-
curred at a higher frequency in cases than in controls
(x2  1, df  7.38, P  .0066), and the other haplotype
(H4), consisting of the rarer allelic counterparts, was
significantly less common in cases than in controls (x2
1, df  16.86, P ! .0001).
Discussion
Although our understanding of the pathogenesis of
OPLL and related ossification processes has greatly in-
creased in recent years, particularly with regard to the
role of bone morphogenetic proteins, activins, and/or
transforming–growth-factor interactions in ossification
(Kawaguchi et al. 1992; Hayashi et al. 1997; Yonemori
et al. 1997), the molecular cause of this common dis-
order remains unknown. Identification of the genetic
susceptibility of the disease is the first step toward an
understanding of the molecular pathogenesis of OPLL.
It could provide a new biological insight into ectopic
bone formation in the ligament.
We performed the genetic-linkage study in order to
detect the locus of the disease. In the case of OPLL, a
mode of inheritance has not been clearly established, and
large-pedigree ascertainment is not practical, because of
the late onset of the disease. A total of 91 affected sib
pairs were selected from various orthopedic hospitals in
Japan. HLA haplotype analysis with modest numbers of
families suggested that the disease-susceptibility locus
lies in the HLA region (Sakou et al. 1991). Affected-sib-
pair linkage analysis of a nonparametric method was
tested with seven markers at the HLA region. We de-
tected, among the markers tested, both a strong linkage
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Table 3
Estimated Haplotype Frequency in OPLL and Non-OPLL Subjects
HAPLOTYPEa
FREQUENCY
x 2 (df  1) P
OPLL
(n  96 [192
Chromosomes])
Non-OPLL
(n  136 [272
Chromosomes])
H1 () .610 .482 7.38 .0066
H2 () .159 .147 .026 .87
H3 () .096 .107 .33 .56
H4 () .080 .220 16.86 !.0001
Other .055 .044 1.65 .20
a A plus sign () denotes wild-type allele, and a minus sign () denotes the mutant allele;
the marker order, from left to right, is as follows: position 182, intron 6, exon 43, and exon
46.
with D6S276 and weaker linkages with other neigh-
boring markers (table 1).
We considered the possibility that COL11A2 could
be a candidate gene for OPLL, because of its potential
involvement in the ossification process and its chro-
mosomal location, which is proximal to HLA class II,
between the markers D6S276 and D6S291. The fact that
COL11A2 does not occur precisely at the peak of link-
age could be due to differences in information content
of the marker that contribute differently to the sib-pair
linkage study. It is known that relatively small changes
in the frequencies of rare alleles can dramatically alter
linkage results. Therefore, our sib-pair linkage analysis
might not necessarily pinpoint the precise genetic locus.
In Alzheimer disease, apolipoprotein E4 is well recog-
nized as a risk factor. Despite the fact that apolipopro-
tein-E association was highly and consistently signifi-
cant, linkage analysis at the ApoE/ApoC2 locus gave
weak evidence for linkage (Pericak-Vance et al. 1991;
Liu et al. 1996). The potential role of collagen in the
pathogenesis of OPLL is supported by several lines of
evidence. Typical findings during histopathological ex-
amination of the ossified ligament from OPLL subjects
are proliferation of active chondrocytes at the area of
the ossification front and thickening of the ligaments
(Yamazaki and Goto 1992). This heterotopic bone for-
mation is dominated by endochondral ossification. It is
well recognized that collagen plays a key role in the
ossification process and that the collagens a1(XI) and
a2(XI) are the minor components of the extracellular
matrix of chondrocytes (Line et al. 1993). Furthermore,
the tiptoe-walking Yoshimura (twy) mouse, which has
been considered as an animal model for OPLL, is char-
acterized by hyperostosis of the ligaments, along with
elevated expression of collagen a1(XI) (Yamazaki et al.
1991). Mutations in COL11A2 have been implicated in
two distinct human osteochondrodysplasias—an auto-
somal dominant form (Stickler syndrome) and a reces-
sive form with severe spondyloepiphyseal dysplasia and
sensorineural hearing loss (Vikkula et al. 1995). Finally,
an association study of a BamHI RFLP polymorphism
withinCOL11A2 has documented significant (P .018)
allelic association with OPLL (Koga et al. 1996) .
Among the 19 molecular variants of COL11A2 that
have been identified thus far, significant associations
with OPLL were observed for 4 (table 2), and none of
them are obvious disease-causing mutations. The func-
tional impacts of these variants onCOL11A2 expression
are currently obscure. A variant in the promoter, at po-
sition 182, could potentially affect the transcriptional
level of COL11A2. The intron 6 variant is located four
bases upstream of the splicing junction; therefore, this
variant may affect the splicing pattern. The exon 43
variant and the exon 46 variant are silent mutations.
Recently, several reports (Wakamatsu et al. 1992; Liu et
al. 1997) have suggested the possibility that a silent mu-
tation in an exon has an impact on the splicing pattern;
this possibility needs to be examined for the exon 43
variant and the exon 46 variant.
Haplotype analysis is a powerful method for testing
the hypothesis that a specific allele mediates predispo-
sition of the disease, especially when causal variants in-
volved in the disease have not been identified. With four
distinct diallelic polymorphisms (position 182, intron
6, exon 43, and exon 46), the haplotype was subdivided
on the basis of a maximum-likelihood method. Inter-
estingly, very strong significance was found with two
haplotypes—namely, H1, with all common alleles at
each site, and H4 with all rare alleles at each site (table
3). Conceivably, these results could support the hypoth-
esis that there exists an OPLL-predisposing allele and an
OPLL-protective allele, within or near COL11A2.
When taken together, these observations of linkage,
association, and haplotype analysis show that a genetic
locus for OPLL lies close to the HLA region on chro-
mosome 6p in the Japanese population. This study of
an OPLL-susceptibility gene is the first step in the iden-
tification of this common disease-causing gene. Identi-
fication of the disease-susceptibility gene could lead to
a better understanding of the molecular pathogenesis of
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this disease and could provide new biological insights
into heterotopic bone formation in ligaments.
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